Stock Chart

WAT

$425.53 -3.15%
Score: 43.4 HOLD
LEAPs: SELL $300
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $300
Premium: $44.53
Expiry: Jan 15, 2027
Target: $273
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.18x (vs SPY: 1.1x | vs QQQ: 1.1x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 01, 2026
Rising Channel weak / forming — below our quality gate quality 45/100
A Rising Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Lower rail breaks first 80% of the time (n=1,744) — a trend-exit tell, not a crash call
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About WAT - Waters Corp

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. …

Key Statistics

Market Cap $43B
P/E Ratio 111.24

This WAT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track WAT's price movements with trendlines, gamma walls, and key support/resistance levels.